Literature DB >> 20666603

Effect of varicella-zoster virus (VZV) fluorescent-antibody-to-membrane-antigen (FAMA) testing on sensitivity of determining VZV immunity in healthcare workers and on furlough days.

Lori Rolando1, William J Schneider, Sharon Steinberg, Sulin Low, Jeffrey Stiles, Luz Gomez, Anne A Gershon, Arthur E Brown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20666603      PMCID： PMC5391034          DOI： 10.1086/655840

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


× No keyword cloud information.
  9 in total

1.  Screening healthcare workers for varicella-zoster virus: can we trust the history?

Authors:  Maha Almuneef; Ziad A Memish; Mostafa E Abbas; Hanan H Balkhy
Journal:  Infect Control Hosp Epidemiol       Date:  2004-07       Impact factor: 3.254

2.  Comparison of fluorescent-antibody-to-membrane-antigen test, indirect immunofluorescence assay, and a commercial enzyme-linked immunosorbent assay for determination of antibody to varicella-zoster virus.

Authors:  M L Landry; S D Cohen; D R Mayo; C K Fong; W A Andiman
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

3.  Comparison of five assays for antibody to varicella-zoster virus and the fluorescent-antibody-to-membrane-antigen test.

Authors:  P Larussa; S Steinberg; E Waithe; B Hanna; R Holzman
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

4.  Impact and costs of varicella prevention in a university hospital.

Authors:  D J Weber; W A Rutala; C Parham
Journal:  Am J Public Health       Date:  1988-01       Impact factor: 9.308

5.  Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence.

Authors:  V Williams; A Gershon; P A Brunell
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

6.  Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen.

Authors:  A Sauerbrei; P Wutzler
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

7.  Susceptibility to varicella zoster virus infection in health care workers.

Authors:  J Gallagher; B Quaid; B Cryan
Journal:  Occup Med (Lond)       Date:  1996-08       Impact factor: 1.611

Review 8.  Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.

Authors:  Judith Breuer; D Scott Schmid; Anne A Gershon
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

9.  Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Mona Marin; Dalya Güris; Sandra S Chaves; Scott Schmid; Jane F Seward
Journal:  MMWR Recomm Rep       Date:  2007-06-22
  9 in total
  2 in total

Review 1.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

2.  Seroepidemiology of varicella-zoster virus in Korean adolescents and adults using fluorescent antibody to membrane antigen test.

Authors:  S B Han; K R Kang; D H Huh; H C Lee; J H Kim; J H Kang; S H Ma
Journal:  Epidemiol Infect       Date:  2014-09-19       Impact factor: 2.451
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.